Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fio

Explore full profile

Fio operates at the intersection between healthcare delivery and data, strengthening decentralized management of infectious diseases

Toronto, CanadaFounded 2006Biotech & Life Sciences
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Fio and the history behind them.

About Fio

Fio Corporation, through its Fionet Suite, delivers innovative mobile technology solutions aimed at enhancing community-based healthcare. The company operates in the healthcare technology market, focusing on providing tools that ensure consistent case management, accurate diagnostic testing, and reliable data collection from village settings to health centers. Fio's core product, the Fionet Suite, integrates mobile electronic medical records (EMR), diagnostic tools, and data services to bring healthcare directly to patients, rather than requiring patients to visit medical centers. This approach is particularly beneficial in remote or underserved areas where access to healthcare facilities is limited.

Fio serves a diverse range of clients including local distribution partners, service and support organizations, and government agencies such as the US Department of Defense. The company has demonstrated its global reach and adaptability by successfully implementing its solutions in Africa, North America, and Europe. During the COVID-19 pandemic, Fio's technology proved critical in upscaling frontline diagnosis and treatment, showcasing its capability to adapt to urgent healthcare needs.

The business model of Fio involves partnering with dominant laboratory companies and leading diagnostic technology firms to integrate their tools into the Fionet Suite. Revenue is generated through the sale of these integrated solutions, as well as through partnerships and service agreements with healthcare providers and government agencies.

Source: Dealroom company data

At a glance

Founded
2006
Headquarters
Toronto, Canada
Sector
Biotech & Life Sciences

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • Hammerstone Capital
  • Kupanda Capital
  • Indigo Capital Partners
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇦 Canada51.6%
🇳🇬 Nigeria25.8%
🏳️ Rwanda19.4%
🇺🇸 United States3.2%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Fio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.